Association of medical noncompliance and long-term adverse outcomes, after myocardial infarction in a minority and uninsured population

Treatment, Outcomes, and Adherence to Medication Regimens Among Dual Medicare-Medicaid–Eligible Adults With Myocardial Infarction

“…Adherence to medications after MI affects survival. [30][31][32] Lowerincome and older patients are at greater risk of cost-related medication nonadherence, 13,33 so poor medication adherence is a potential cause of outcome disparities for dual-eligible patients. Instead, our analysis indicated that dual-eligible patients were more likely to adhere to secondary prevention medications than Medicare-only patients, though overall adherence to all prescribed cardiovascular medications was low for both groups.…”

Challenges and solutions in medically managed ACS in the Asia-Pacific region: Expert recommendations from the Asia-Pacific ACS Medical Management Working Group

“…Poor compliance, both in terms of lifestyle modification and adherence to drug therapy, complicates the secondary prevention of CVD and is independently associated with socioeconomic status, number of prescribed medications, lower educational status [105], and mortality [106,107]. While patient education programs that include information on drug compliance, diet and smoking cessation have been successfully implemented in the past by community health workers and physician assistants within the APAC region, geographical barriers in some countries prohibit formal cardiac follow-up rehabilitation programs.…”

Impacts of Type D Personality and Depression, Alone and in Combination, on Medication Non-Adherence Following Percutaneous Coronary Intervention

“…According to a previous study, the percentage of patients adherent to both antihypertensive and lipid-lowering therapy declined sharply following treatment initiation, with 44.7%, 35.9%, and 35.8% of patients adherent at 3, 6, and 12 months, respectively [ 7 ]. According to another study, patients who were not compliant with four or more cardio-related medications had about a three times higher risk of mortality and reinfarction rates [ 8 ].…”